ZA801328B - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: ZA801328B
Authority: ZA; South Africa
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1979-03-07

Application number

ZA00801328A

Other languages

English (en)

Inventor

P Cross

R Dickenson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-03-06

Publication date

1981-03-25

1980-03-06 Application filed by Pfizer filed Critical Pfizer

1981-03-25 Publication of ZA801328B publication Critical patent/ZA801328B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

ZA00801328A 1979-03-07 1980-03-06 Therapeutic agents ZA801328B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07

Publications (1)

Publication Number	Publication Date
ZA801328B true ZA801328B (en)	1981-03-25

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA00801328A ZA801328B (en)	1979-03-07	1980-03-06	Therapeutic agents

Country Status (36)

Country	Link
US (1)	US4273782A (nl)
JP (1)	JPS55133380A (nl)
KR (1)	KR850000760B1 (nl)
AR (1)	AR227015A1 (nl)
AT (1)	AT375366B (nl)
AU (1)	AU516957B2 (nl)
BE (1)	BE882113A (nl)
CA (1)	CA1120479A (nl)
CH (1)	CH649546A5 (nl)
CS (1)	CS253702B2 (nl)
DD (1)	DD149525A5 (nl)
DE (1)	DE3008632A1 (nl)
DK (1)	DK151884C (nl)
ES (2)	ES489220A0 (nl)
FI (1)	FI66860C (nl)
FR (1)	FR2450832A1 (nl)
GR (1)	GR67237B (nl)
HK (1)	HK89884A (nl)
HU (1)	HU184727B (nl)
IE (1)	IE49542B1 (nl)
IL (1)	IL59524A (nl)
IT (1)	IT1218420B (nl)
KE (1)	KE3467A (nl)
LU (1)	LU82224A1 (nl)
MY (1)	MY8500285A (nl)
NL (1)	NL182959C (nl)
NO (1)	NO152217C (nl)
NZ (1)	NZ193052A (nl)
PH (1)	PH15198A (nl)
PL (1)	PL128296B1 (nl)
PT (1)	PT70914A (nl)
SE (1)	SE440778B (nl)
SG (1)	SG67284G (nl)
SU (1)	SU1277894A3 (nl)
YU (1)	YU41911B (nl)
ZA (1)	ZA801328B (nl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	인돌 유도체의 제조방법
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
AT376436B (de) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
DE3786030T2 (de)	1986-03-27	1993-12-02	Merck Frosst Canada Inc	Tetrahydrocarbazole Ester.
JPH0832679B2 (ja) *	1986-09-05	1996-03-29	理化学研究所	Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
KR920700210A (ko) *	1989-03-31	1992-02-19	기따미 가즈히꼬	신규 이미다졸 유도체, 그의 제법 및 그의 의약용도
MC2210A1 (fr) *	1990-06-07	1992-11-26	Wellcome Found	Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
PT98927A (pt) *	1990-09-13	1992-07-31	Beecham Group Plc	Processo para a preparacao de piridil-indolil-ureias
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
ZA929788B (en) *	1991-12-18	1993-06-22	Schering Corp	Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring.
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
CA2109931A1 (en) *	1992-03-27	1993-10-14	Hiroshi Matsui	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) *	1992-09-18	1994-04-28	三洋電機株式会社	床暖房用パネル
US6214991B1 (en) *	1998-03-31	2001-04-10	The Institute For Pharmaceutical Discovery, Inc.	Substituted indolealkanoic acids
RU2296759C2 (ru) *	2002-09-12	2007-04-10	Ф.Хоффманн-Ля Рош Аг	N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
ES2312819T3 (es) *	2002-11-25	2009-03-01	F. Hoffmann-La Roche Ag	Derivados de indolilo.
DK1569899T3 (da) *	2002-12-10	2006-10-23	Wyeth Corp	Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
GB0324763D0 (en) *	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
BRPI0510599A (pt) *	2004-05-03	2007-11-20	Hoffmann La Roche	compostos, processo para a preparação dos mesmos, composição farmacêutica, uso de um composto, e método para o tratamento e a profilaxia de doenças
KR20070091607A (ko) *	2004-10-12	2007-09-11	디코드 제네틱스, 아이엔씨.	폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
AR056043A1 (es) *	2005-08-25	2007-09-12	Schering Corp	Agonistas de receptores adrenergicos alfa2c funcionalmente selectivos
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) *	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
RU2008149518A (ru) *	2006-05-16	2010-06-27	Декод Дженетикс, Ехф. (Is)	Способ получения 7-(акрилоил) индолов
EP2046740B1 (en)	2006-07-22	2012-05-23	Oxagen Limited	Compounds having crth2 antagonist activity
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
AU2008350907A1 (en)	2007-12-11	2009-08-27	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
ES2442717T3 (es)	2008-01-18	2014-02-13	Atopix Therapeutics Limited	Compuestos que tienen actividad antagonista de CRTH2
US7750027B2 (en) *	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
WO2009093029A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
WO2009093026A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
MX2010012814A (es) *	2008-05-23	2010-12-20	Amira Pharmaceuticals Inc	Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
JP2014518223A (ja) *	2011-06-20	2014-07-28	アルツハイマーズ・インスティテュート・オブ・アメリカ・インコーポレイテッド	化合物とその治療用途
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
WO2019191410A1 (en) *	2018-03-29	2019-10-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (nl) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
DK376078A (da) *	1977-08-26	1979-02-27	Wellcome Found	Fremgangsmaade til fremstilling af amidazoler
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) *	1978-02-24	1981-08-05	Pfizer Limited	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/da active
- 1980-03-04 CS CS801492A patent/CS253702B2/cs unknown
- 1980-03-04 HU HU80498A patent/HU184727B/hu not_active IP Right Cessation
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-05 YU YU614/80A patent/YU41911B/xx unknown
- 1980-03-05 FI FI800672A patent/FI66860C/fi not_active IP Right Cessation
- 1980-03-05 LU LU82224A patent/LU82224A1/fr unknown
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 SU SU802891745A patent/SU1277894A3/ru active
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-05 SE SE8001736A patent/SE440778B/sv not_active IP Right Cessation
- 1980-03-05 ES ES489220A patent/ES489220A0/es active Granted
- 1980-03-05 IL IL59524A patent/IL59524A/xx unknown
- 1980-03-05 PL PL1980222470A patent/PL128296B1/pl unknown
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/nl not_active IP Right Cessation
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/it active
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/xx unknown
- 1980-03-06 JP JP2856380A patent/JPS55133380A/ja active Granted
- 1980-03-06 BE BE0/199699A patent/BE882113A/fr not_active IP Right Cessation
- 1980-03-06 CH CH1781/80A patent/CH649546A5/de not_active IP Right Cessation
- 1980-03-06 AT AT0125780A patent/AT375366B/de not_active IP Right Cessation
- 1980-03-06 DD DD80219495A patent/DD149525A5/de not_active IP Right Cessation
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/de active Granted
- 1980-03-06 AR AR280198A patent/AR227015A1/es active
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/ko not_active Expired
- 1980-03-06 FR FR8005054A patent/FR2450832A1/fr active Granted
- 1980-03-06 PT PT70914A patent/PT70914A/pt not_active IP Right Cessation
- 1980-03-06 NO NO800650A patent/NO152217C/no unknown
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-11-14 ES ES496889A patent/ES8205789A1/es not_active Expired
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/xx unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/xx unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/xx unknown

Also Published As

Publication number	Publication date
ES8104278A1 (es)	1981-04-01
DE3008632A1 (de)	1980-10-16
FI66860B (fi)	1984-08-31
PL222470A1 (nl)	1980-12-01
ATA125780A (de)	1983-12-15
MY8500285A (en)	1985-12-31
DK151884B (da)	1988-01-11
DK151884C (da)	1988-06-13
NZ193052A (en)	1984-07-06
HU184727B (en)	1984-10-29
FR2450832B1 (nl)	1983-04-22
LU82224A1 (fr)	1980-06-06
DE3008632C2 (nl)	1988-02-25
KR830001928A (ko)	1983-05-19
FI800672A7 (fi)	1980-09-08
YU61480A (en)	1983-12-31
SG67284G (en)	1985-03-15
SU1277894A3 (ru)	1986-12-15
ES496889A0 (es)	1982-08-01
AT375366B (de)	1984-07-25
IL59524A0 (en)	1980-06-30
IT1218420B (it)	1990-04-19
GR67237B (nl)	1981-06-25
JPS55133380A (en)	1980-10-17
NO800650L (no)	1980-09-08
NL182959C (nl)	1988-06-16
CH649546A5 (de)	1985-05-31
IL59524A (en)	1982-11-30
US4273782A (en)	1981-06-16
ES8205789A1 (es)	1982-08-01
FI66860C (fi)	1984-12-10
FR2450832A1 (fr)	1980-10-03
AU5623180A (en)	1980-09-11
CA1120479A (en)	1982-03-23
SE8001736L (sv)	1980-09-08
NO152217C (no)	1985-08-21
JPS6141513B2 (nl)	1986-09-16
IE800453L (en)	1980-09-07
DK42580A (da)	1980-09-08
NO152217B (no)	1985-05-13
HK89884A (en)	1984-11-23
PH15198A (en)	1982-09-17
ES489220A0 (es)	1981-04-01
DD149525A5 (de)	1981-07-15
IE49542B1 (en)	1985-10-30
PL128296B1 (en)	1984-01-31
PT70914A (en)	1980-04-01
IT8020399A0 (it)	1980-03-06
NL8001351A (nl)	1980-09-09
AR227015A1 (es)	1982-09-15
BE882113A (fr)	1980-09-08
KR850000760B1 (ko)	1985-05-25
AU516957B2 (en)	1981-07-02
SE440778B (sv)	1985-08-19
YU41911B (en)	1988-02-29
KE3467A (en)	1984-11-09
CS253702B2 (en)	1987-12-17

Publication	Publication Date	Title
PH15198A (en)	1982-09-17	Therapeutic agents
GB2000136B (en)	1982-01-06	Therapeutic agents
GB2005248B (en)	1982-03-24	Therapeutic agents
ZA782816B (en)	1979-05-30	Therapeutic agents
ZA80298B (en)	1981-08-26	Therapeutic agents
GB2000138B (en)	1982-03-03	Therapeutic agents
ZA796708B (en)	1981-08-26	Therapeutic agents
GB2000131B (en)	1982-01-13	Therapeutic agents
EG16606A (en)	1989-01-30	Therapeutic agents
ZA792390B (en)	1980-07-30	Therapeutic agents
GB2013181B (en)	1982-06-03	Therapeutic agents
GB2004876B (en)	1982-03-10	Therapeutic agents
GB2007656B (en)	1982-05-19	Therapeutic agents
ZA786184B (en)	1979-10-31	Therapeutic agents
GB2019836B (en)	1982-06-03	Therapeutic agents
GB2047691B (en)	1983-07-20	Therapeutic agents
GB2053910B (en)	1983-04-20	Pyridylaminotriazole therapeutic agents
GB2000510B (en)	1982-01-27	Therapeutic agents
GB2011890B (en)	1982-05-26	Therapeutic agents
GB2010824B (en)	1982-06-16	Therapeutic agents
GB2013179B (en)	1982-06-03	Therapeutic agents
GB2011891B (en)	1982-05-26	Therapeutic agents
GB2008104B (en)	1982-03-10	Therapeutic agents
GB2007654B (en)	1982-06-16	Therapeutic agents
ZA803988B (en)	1982-02-24	Novel therapeutic combinations